THU0200 Lower-Dose Solumatrix® Meloxicam: Efficacy and Safety in A Phase 3 Study in Adults with Osteoarthritis Pain

R Altman,A Gibofsky,M Hochberg,C.L Young,D Parenti

doi:10.1136/annrheumdis-2014-eular.5445

THU0200 Lower-Dose Solumatrix® Meloxicam: Efficacy and Safety in A Phase 3 Study in Adults with Osteoarthritis Pain

R Altman, A Gibofsky + Show 3 more

https://doi.org/10.1136/annrheumdis-2014-eular.5445

Copy DOI

Journal: Annals of the Rheumatic Diseases

Publication Date: Jun 1, 2014

Affiliation: University of California, Los Angeles, Hospital for Special Surgery, University of Maryland, Baltimore, University of Maryland Medical Center

#WOMAC Pain Subscale Score #Osteoarthritis Pain + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

BackgroundNon-steroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed for the management of osteoarthritis (OA) pain. As a class, NSAIDs are associated with dose-related, serious gastrointestinal, cardiovascular, and renal adverse events (AEs),...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.